Article
Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
1 Jul 2018
Abstract excerpt
Background: Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor clinical outcome and limited treatment options. Lacking molecular targets, chemotherapy is the main adjuvant treatment for TNBC patients. Materials and methods: To explore potential therapeutic targets for TNBC, we analyzed three microarray datasets (GSE38959, GSE45827, and GSE65194) derived from the Gene Expression Omnibus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
